"arm_accession","description","name","population_selection_rule",sort_order,"study_accession","type",workspace_id
"ARM1","Placebo omalizumab pre-treatment, placebo RIT, placebo omalizumab + placebo IT","Placebo Immunotherapy with placebo anti-IgE","Randomized 1:1:1:1 to 4 treatment groups",4,"SDY1","Placebo Comparator",990
"ARM2","Placebo omalizumab pre-treatment, ragweed RIT, placebo omalizumab + ragweed IT","Immunotherapy with placebo anti-IgE","Randomized 1:1:1:1 to 4 treatment groups",3,"SDY1","Placebo Comparator",990
"ARM3","Omalizumab pre-treatment, placebo RIT, omalizumab + placebo IT","Placebo Immunotherapy with anti-IgE","Randomized 1:1:1:1 to 4 treatment groups",2,"SDY1","Placebo Comparator",990
"ARM4","Omalizumab pre-treatment, ragweed RIT, omalizumab + ragweed IT","Immunotherapy with anti-IgE","Randomized 1:1:1:1 to 4 treatment groups",1,"SDY1","Experimental",990
